Cited 0 time in
IDF-11774의 타켓 HSP70 암 증식 및 전이 억제 약물의 프루브
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이경 | - |
| dc.contributor.author | 김민경 | - |
| dc.contributor.author | 김보경 | - |
| dc.contributor.author | 반현승 | - |
| dc.contributor.author | 원미선 | - |
| dc.date.accessioned | 2025-09-09T09:32:25Z | - |
| dc.date.available | 2025-09-09T09:32:25Z | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/61099 | - |
| dc.description.abstract | We developed a hypoxia-inducible factor-1 (HIF-1) inhibitor, IDF-11774, as a clinical candidate for cancer therapy. | - |
| dc.title | IDF-11774의 타켓 HSP70 암 증식 및 전이 억제 약물의 프루브 | - |
| dc.title.alternative | IDF-11774 inhibits HSP70 chaperone activity and suppresses HIF-1α accumulation to repress tumor growth through the regulation of cancer metabolism | - |
| dc.type | Patent | - |
| dc.publisher.location | 대한민국 | - |
| dc.contributor.assignee | 동국대학교산학협력단 | - |
| dc.date.application | 2016-06-29 | - |
| dc.date.registration | 2018-12-11 | - |
| dc.type.iprs | 특허 | - |
| dc.identifier.patentRegistrationNumber | 10-1930131 | - |
| dc.identifier.patentApplicationNumber | 10-2016-0081792 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
